Fertility Services Market Size, Share & Trends Analysis Report By Procedure (In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI), Intrauterine Insemination (IUI), In Vitro Fertilization without Intracytoplasmic Sperm Injection (IVF without ICSI), Surrogacy, Others), By Service (Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor, Frozen Donor), By End-User (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Fertility Services Market Size

The global fertility services market size was valued at USD 45.52 billion in 2024 and is projected to reach from USD 48.94 billion in 2025 to USD 87.31 billion by 2033, exhibiting a CAGR of 8.2% during the forecast period (2025-2033).

The rising global infertility rates are significantly driving the expansion of fertility services worldwide. Key factors contributing to infertility include lifestyle changes such as obesity, stress, alcohol consumption, and medical conditions like polycystic ovarian syndrome (PCOS), endometrial tuberculosis, and sexually transmitted diseases (STDs).

According to WHO data from April 2023, approximately 1 in 6 people globally experience infertility, with prevalence rates of 17.8% in high-income countries and 16.5% in low- and middle-income countries. This highlights the urgent need for improved access to affordable, high-quality fertility care, which is anticipated to increase demand for advanced fertility services in the near future. Likewise, the decline in egg quality among older women due to delayed pregnancies further exacerbates the issue.

Innovations in the market are particularly notable, especially in assisted reproductive technologies (ART) like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), which are enhancing treatment options and success rates. There is also a growing trend towards personalized care plans that take into account individual patient needs, medical history, age, and genetic factors, leading to more tailored and effective treatment approaches.

Moreover, a surge in merger and acquisition activity is propelling market growth, driven by increased investment from private equity firms. These firms are investing in new clinics and acquiring established ones to bolster their market presence. For example, in October 2022, Maven Clinic, a U.S. telemedicine provider for women's health, partnered with Indira IVF, a leading infertility clinic in India, to offer Maven members access to quality clinical care and virtual family-building services.

This collaboration reflects the evolving landscape of fertility services and the growing emphasis on integrating technology with traditional care models to enhance patient access and support.

Global Fertility Services Market Trends

Rise in awareness campaigns and supportive government initiatives

Increasing public awareness about infertility through targeted campaigns, along with supportive government policies aimed at addressing infertility issues, are key trends in the fertility services market. These initiatives help reduce the stigma around infertility, educate people on available treatments like IVF, and expand access to fertility services through insurance coverage mandates and policy support, contributing to market growth.

• For instance, in September 2024, Sims IVF launches an 'Any News' campaign to address fertility stigma. The campaign encourages individuals to seek support and promotes greater sensitivity in addressing fecundity issues.

Integration of innovative technology

Companies are adopting advanced technologies such as artificial intelligence (AI), preimplantation genetic testing (PGT), DNA fragmentation index (DFI), and IoT in IVF services to improve outcomes and reduce costs.

• For example, in 2022, Alife, a U.S. startup, introduced AI to optimize embryo selection, thereby enhancing success rates while lowering treatment expenses. Additionally, PGT screens for genetic abnormalities, and DFI assesses sperm health, providing a comprehensive approach to improving fertility treatment outcomes.

Such innovations make fertility treatments more efficient, accessible, and personalized.

Global Fertility Services Market Growth Factors

Increasing demand for assisted reproductive technology

The demand for advanced fertility treatments or assisted reproductive technology, such as in vitro fertilization (IVF), intrauterine insemination (IUI), and IVF without intracytoplasmic sperm injection (ICSI), is steadily increasing. This surge is fueled by factors like delayed childbearing, greater awareness of fertility options, and advancements in reproductive technology.

Additionally, shifting societal norms, evolving lifestyle choices and the growing need for family planning support are driving more individuals and couples to seek fertility treatments, further boosting demand for these services.

• For instance, in April 2022, according to the American Society for Reproductive Medicine, the number of babies born through IVF rose from 89,208 in 2021 to 91,771 in 2022, making up 2.5% of all U.S. births attributed to assisted reproductive technology (ART) cycles.

As awareness of fertility treatments continues to rise, alongside technological advancements, the global market is poised for sustained growth, meeting the needs of a diverse population seeking to achieve their family-building goals.

Broadening access to intrauterine insemination (IUI) coverage

The expansion of fertility coverage, particularly for cost-effective treatments like intrauterine insemination (IUI), is significantly driving market growth. As infertility rates continue to rise, the increased availability of insurance coverage and government support for fertility services is making treatments more accessible to a broader population. This accessibility is crucial for individuals and couples seeking to start families.

• For instance, in August 2024, Aetna introduced intrauterine insemination (IUI) as a covered benefit for eligible plans, enhancing access to fertility treatments for all individuals. By lowering the financial barriers associated with IUI, Aetna’s initiative is expected to increase the utilization of fertility services, thereby contributing to the overall growth of the fertility services market.

This trend reflects a broader movement toward inclusivity and support for diverse family structures, reinforcing the demand for effective fertility treatments and driving advancements in the sector.

Restraining Factors

High costs of IVF treatment

The high cost of fertility treatments, especially IVF, presents a significant financial challenge for many individuals. With limited insurance coverage and considerable variability in out-of-pocket expenses, these treatments often deter potential patients.

• IVF treatment costs, including medications and related testing, typically range from USD 11,000 to USD 18,000 per cycle, representing a substantial investment. While some funding programs are available, access is inconsistent and varies by region.

This financial barrier underscores the need for more comprehensive solutions to improve affordability and accessibility in the fertility treatment market.

Market Opportunities

Reducing multiple birth risks through advanced fertility treatment technologies

A significant challenge in fertility treatments, particularly in in-vitro fertilization (IVF), is the heightened likelihood of multiple pregnancies. For example, in August 2023, the Human Fertilization and Embryo Authority reported that one out of five IVF pregnancies resulted in twin pregnancies or multiple births. This raises critical concerns regarding the associated health risks for both mothers and infants.

Consequently, reducing the risk of multiple births through advanced fertility treatment technologies presents a substantial opportunity for companies in the fertility services industry. By investing in innovations such as single embryo transfer (SET), Preimplantation Genetic Testing (PGT), and AI-driven embryo selection, fertility clinics can provide safer and more effective treatment options. These technologies facilitate more precise embryo selection, thereby minimizing the need for multiple embryo transfers and significantly lowering the risk of multiple pregnancies.

By championing these advancements, companies can distinguish themselves in a competitive landscape by offering safer, more ethical fertility solutions. This proactive approach not only addresses patient concerns about the health implications of multiple births but also appeals to a broader patient base seeking reliable and responsible reproductive healthcare options.

Regional Insights

North America: Dominant region with 36.5% market share

North America leads the global fertility services market due to its advanced healthcare infrastructure, significant demand for fertility treatments driven by delayed family planning, and greater awareness of available fertility options. Government initiatives and insurance coverage for treatments like IVF have further increased accessibility. Moreover, declining fertility rates in North America for the past few years are a key factor driving regional growth.

• For instance, in April 2024, according to the Centers for Disease Control and Prevention, the U.S. fertility rate hit a historic low in 2023, dropping by 3% from 2022, with 3,591,328 births recorded.

This trend underscores the urgency for comprehensive fertility services to address the evolving reproductive health landscape in the region.

Asia Pacific: Fastest growing region with the highest market CAGR

The Asia Pacific region is expected to witness the fastest growth rate in the market. Countries such as India, China, and Japan are key players in this growth, with a growing number of fertility clinics and access to advanced treatments such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Favorable government policies, such as the relaxation of fertility treatment regulations and subsidies for treatment, are also contributing to the market's rapid growth.

• For instance, in August 2023, the Indian Council of Medical Research (ICMR) introduced national guidelines for the accreditation, supervision, and regulation of Assisted Reproductive Technology (ART) clinics across India.

Additionally, under the Indian Public Health Standards (IPHS) 2022, infertility counseling is now a mandatory service at Primary Health Centers (PHCs), Urban-PHCs, and Polyclinics, improving access to fertility care across healthcare facilities nationwide.

Such initiatives aimed at strengthening reproductive health services across the country contribute to the market's rapid growth in the region.

Country Insights

The global fertility services market is growing rapidly due to rising infertility rates, advancements in assisted reproductive technologies such as IVF, and shifting social norms around family planning.

Below is the analysis of key countries impacting the market:

• U.S.- The U.S. fertility services sector leads the market, bolstered by supportive governmental initiatives. In April 2023, the federal government introduced a benefit plan for its employees, offering a median lifetime maximum benefit of $20,000 for in vitro fertilization (IVF). Employees can choose plans that cover various fertility services, including up to $25,000 annually for IVF procedures and up to three artificial insemination cycles per year, making fertility treatments more accessible.
• Japan- Japan faces a low fertility rate due to several factors, including delayed marriages, a decrease in overall marriages, a significant gender gap in unpaid housework, and many women working in non-regular employment, perpetuating the gender wage gap. According to the International Monetary Fund, in May 2024, the number of births in Japan reached a record low, with the fertility rate dropping to approximately 1.26 in 2022—one of the lowest among G7 economies. These challenges contribute to an increasing demand for fertility services in the country.
• India- In February 2024, the Maharashtra government announced the provision of free in vitro fertilization (IVF) treatments at select government-run hospitals, valued at over ₹2 lakh in private clinics. This initiative addresses infertility challenges across the state, making IVF accessible to thousands of couples, including those in rural areas. The move is expected to provide hope to infertile couples by offering advanced fertility treatments at no cost, regardless of their economic background.
• China: In June 2023, Beijing announced that it would cover 16 types of assisted reproductive technologies under its healthcare system, effective July 1. This initiative aims to address China’s declining birth rate, which fell to a record low of 6.77 per 1,000 people last year. Treatments covered include in vitro fertilization and embryo transplantation. Moreover, the National Health Commission has issued guidance to support fertility rates, with ongoing discussions about expanding access to fertility treatments for unmarried women. These measures are expected to bolster demand in China’s already significant fertility services market.
• Germany- Companies in Germany are increasingly focusing on digital technology to support market growth. In April 2024, Berlin-based fertility startup Ovom Care secured $5.34 million in seed funding to further develop its Ovom Technology Ecosystem and expand its hybrid care model throughout the country.
• France: In January 2024, the French government proposed free fertility tests for 25-year-olds as part of routine medical checkups to combat rising infertility and the declining birthrate. Additionally, in June 2021, France passed legislation granting single women and those in same-sex partnerships access to IVF and other fertility treatments. This reform, widely supported by the public, allows women to access treatment without needing a male partner, enhancing the inclusivity of fertility services in the country.

Fertility Services Market Segmentation Analysis

By Procedure

The market is bifurcated into in vitro fertilization with intracytoplasmic sperm injection (IVF with ICSI), intrauterine insemination (IUI), in vitro fertilization without intracytoplasmic sperm injection (IVF without ICSI), surrogacy, and others. The in vitro fertilization with intracytoplasmic sperm injection (ICSI) segment dominates the market, holding the largest market revenue. This procedure is widely used, especially for male infertility, as it increases the chances of successful fertilization by injecting a single sperm directly into the egg. The growing awareness of infertility treatments, combined with advancements in assisted reproductive technology (ART), led to an increasing preference for IVF with ICSI, driving market growth. The segment continues to dominate due to its higher success rates compared to IVF without ICSI.

By Service

The market is bifurcated into fresh non-donor, frozen non-donor, egg & embryo banking, fresh donor, and frozen donor. The fresh non-donor segment dominates the market, holding the largest market revenue primarily driven by the preference for fresh embryos in IVF procedures. Fresh embryos are generally associated with higher success rates than frozen ones, as they are perceived to be more viable. This perception contributes to higher live birth rates, making fresh embryo transfers a preferred choice for many patients and thus significantly boosting this segment's growth in the market.

By End-User

The market is bifurcated into fertility clinics, hospitals, surgical centers, and clinical research institutes. The fertility clinics segment dominates the market, holding the largest market revenue due to their specialized expertise, advanced facilities, and focus on comprehensive reproductive health services. These clinics offer cutting-edge fertility treatments such as IVF, IUI, and genetic testing, attracting a growing number of patients seeking specialized care. The rise in dedicated fertility centers worldwide and the increasing demand for fertility treatments have further solidified the dominance of this segment.

• For instance, in June 2023, according to the Centers for Disease Control and Prevention, approximately 500 clinics in the U.S. provided services to patients overcoming infertility, highlighting the growing infrastructure and capacity of fertility clinics to meet rising demand.

Company Market Share

The fertility services market is highly fragmented, offering valuable market insights into the competitive landscape, with numerous local and regional players contributing to its growth. Key industry leaders such as Merck KGaA, Apollo Hospitals Enterprise Ltd., Monash IVF Group, and Virtus Health are at the forefront of innovation and expanding service portfolios.

Firms like Apricity Fertility UK Limited, King’s Fertility Limited, and Aspire Fertility contribute significantly by offering advanced technologies and specialized services. This broad competition highlights the rapid expansion and dynamic evolution of such a market, with continuous innovation and service diversification shaping the industry.

Virtus Health: An emerging player in the fertility services market

Virtus Health is an emerging leader in fertility and reproductive health services and holds a market-leading position in Australia, Ireland, and Denmark and is expanding its presence in the UK and Singapore.

Virtus Health offers a comprehensive range of services, including fertility treatment, IVF, and advanced reproductive genetics. They operate across three continents with 43 fertility clinics, 63 laboratories, and seven-day hospitals that support fertility and a wide array of medical services.

Recent developments at Virtus Health include:

• In December 2023, Virtus Health received a USD 3 million grant from the Australian federal government’s Medical Research Future Fund (MRFF) for a world-first IVF study. This research, in collaboration with Monash University and health tech startup 23Strands, focuses on whole genome sequencing used to improve patient outcomes for IVF treatments.

Recent Developments

• August 2024 - Alchemist-Ojas Hospital in Panchkula launched its advanced infertility treatment and IVF services, offering state-of-the-art technology and personalized care. The facility is equipped to provide comprehensive fertility treatments, catering to couples facing challenges in conceiving. The hospital aims to bring high-quality and affordable fertility care to the region, addressing the growing demand for such services. 

Analyst Opinion

As per our analyst, the global fertility services market presents significant growth opportunities to companies that leverage advance technologies to improve success rates and differentiate from competitors. Companies looking to gain the largest market share should implement flexible financing options to make treatments more accessible and expand into underserved regions, utilizing telehealth to increase patient reach.

Addressing ethical concerns by limiting embryo transfers to reduce multiple pregnancy risks and ensuring compliance with evolving regulations is also a key factor for the growth. Companies should consider strategic partnerships or consolidation to achieve operational efficiencies while maintaining high-quality care. These strategies will help them gain a competitive advantage and sustainable growth in the fertility sector.